VERACYTE, INC. VCYT

Rank #2052 · Nasdaq · $4.0B market cap

Audited by Ernst & Young LLP, no going-concern flag in the latest filing.

Score

35.2

P/E

-53.6

P/B

3.71

ROE

-6.9%

Op. Margin

-23.8%

Debt Ratio

12%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Weak

P/E -53.6x, P/B 3.71x. Ranks in the top 64% of the universe.

Profitability ★☆☆☆☆

Weak

ROE -6.9%. Ranks in the top 78% of the universe.

Safety ★★★★☆

Excellent

Debt ratio 12%. Ranks in the top 10% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★☆

Excellent

Revenue growth of 21.8% year over year. Ranks in the top 17% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2013	–	$-0.0B	–	$-0.0B	–	-53
2014	–	$-0.0B	–	$-0.0B	–	-57
2015	–	$-0.0B	–	$-0.1B	–	-40
2016	–	$-0.0B	–	$0.1B	–	43
2017	–	$-0.0B	–	$0.0B	–	100
2018	$0.1B	$-0.0B	–	$0.1B	-44.3	81
2019	$0.1B	$-0.0B	–	$0.1B	-36.9	69
2020	$0.1B	$-0.0B	$-0.0B	$0.0B	-24.2	96
2021	$0.1B	$-0.0B	$-0.0B	$0.1B	-12.6	45
2022	$0.1B	$-0.0B	$-0.0B	$0.2B	-30.1	38
2023	$0.2B	$-0.1B	$-0.1B	$0.4B	-37.3	19
2024	$0.3B	$-0.0B	$-0.0B	$1.1B	-13.9	6
2025	$0.4B	$-0.1B	$-0.1B	$1.1B	-23.8	12